* Rapid Micro Biosystems Inc reported a quarterly adjusted loss of 26 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -31 cents. The mean expectation of two analysts for the quarter was for a loss of 25 cents per share. Wall Street expected results to range from -26 cents to -25 cents per share.

* Revenue rose 23.7% to $7.60 million from a year ago; analysts expected $6.55 million.

* Rapid Micro Biosystems Inc's reported EPS for the quarter was a loss of 26 cents​.

* The company reported a quarterly loss of $11.32 million.

* Rapid Micro Biosystems Inc shares had risen by 21.3% this quarter and gained 45.9% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts had fallen by about 0.7% in the last three months.​

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

Wall Street's median 12-month price target for Rapid Micro Biosystems Inc is $8.00 This summary was machine generated from LSEG data November 1 at 02:25 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 -0.25 -0.26 Missed

Jun. 30 2024 -0.28 -0.29 Missed

Mar. 31 2024 -0.29 -0.31 Missed

Dec. 31 2023 -0.30 -0.26 Beat